Doctors are increasingly turning to monoclonal-antibody drugs to treat high-risk patients who get sick with Covid-19. WSJ takes a look at how the therapies work and why they’re important for saving lives. Illustration: Jacob Reynolds/WSJ

More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com
Visit the WSJ Video Center: https://wsj.com/video

On Facebook:   / videos  
On Twitter:   / wsj  
On Snapchat: https://on.wsj.com/2ratjSM

#WSJ #monoclonalantibodies #antibodytreatment